Use of prostate-specific antigen testing in Medicare beneficiaries: Association with previous evaluation

Use of prostate-specific antigen testing in Medicare beneficiaries: Association with previous evaluation

Objective: Determine uptake of prostate-specific antigen (PSA) testing in Medicare beneficiaries according to previous receipt of PSA testing. Methods: A 5% random sample of men aged 67 years or older without a previous diagnosis of prostate cancer was identified through 2009–2012 Medicare claims. W...

Full description

Bibliographic Details
Main Authors:	Gregory S. Cooper, Tzuyung Doug Kou, Mark D. Schluchter, Avi Dor, Siran M. Koroukian, Simon P. Kim
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2017-07-01
Series:	Family Medicine and Community Health
Subjects:	Prostate-specific antigen Medicare mass screening clinical practice patterns
Online Access:	http://www.ingentaconnect.com/content/cscript/fmch/2017/00000005/00000002/art00003

Similar Items

Watchful Waiting Active Surveillance in Prostate Cancer Patients – a Population-Based Study Using the SEER-Medicare Linked Database
by: Kou, Tzuyung Doug
Published: (2008)

Statin Medication Acquisition Among Medicare Beneficiaries 1992-2002
by: Peterson, Mikael, et al.
Published: (2007)

Community-based case management and outcomes in Medicare beneficiaries
by: Joo, Jee Young
Published: (2013)

Economic burden of hospitalizations of Medicare beneficiaries with heart failure
by: Kilgore M, et al.
Published: (2017-05-01)

Bariatric surgery outcomes in Medicare beneficiaries
by: Keith Wirth, et al.
Published: (2021-04-01)

Seniors don’t use Medicare.Gov: how do eligible beneficiaries obtain information about Medicare Advantage Plans in the United States?
by: Maricruz Rivera-Hernandez, et al.
Published: (2021-02-01)

The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?
by: Deepak Dubey
Published: (2009-01-01)

Controversies in Prostate Cancer Screening: is the Prostate Specific Antigen useful?
by: Pablo Yago Giménez, et al.
Published: (2019-12-01)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01)

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization
by: Rulin C. Hechter, et al.
Published: (2017-07-01)

Beyond prostate-specific antigen: alternatives for prostate neoplasm screening
by: Yu, Kevin Kuo-Han
Published: (2016)

The Limited English Proficient Population: Describing Medicare, Medicaid, and Dual Beneficiaries
by: Kimberly Proctor, et al.
Published: (2018-05-01)

Prostate-Specific antigen: An overview and its current status in the diagnosis of prostate cancer
by: Siddalingeshwar Neeli, et al.
Published: (2021-01-01)

Adding a prescription drug benefit to Medicare: an analysis of the Medicare Prescription Drug, improvement, and modernization act of 2003
by: Jones, Carla D.
Published: (2012)

Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries
by: Namino M. Glantz, et al.
Published: (2019-05-01)

Hospice utilization of Medicare beneficiaries in Hawai‘i compared to other states
by: Deborah Taira, et al.
Published: (2017-11-01)

Bridging the Gap: Collaboration between a School of Pharmacy, Public Health, and Governmental Organizations to provide Clinical and Economic Services to Medicare Beneficiaries
by: Rajul Patel, et al.
Published: (2018-01-01)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
by: Yasuhide Kitagawa, et al.
Published: (2014-12-01)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
by: Won Ki Lee, et al.
Published: (2014-08-01)

Medicare finances: a review
by: Gilbert Berdine
Published: (2016-04-01)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
by: R. Jeffrey Karnes, et al.
Published: (2018-08-01)

Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers
by: Tara A. Lavelle, et al.
Published: (2018-01-01)

Effect of ejaculation on serum prostate specific antigen level in screening and non-screening population
by: Mohammad Rajaei, et al.
Published: (2013-01-01)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
by: Ahmed S. Zakaria, et al.
Published: (2018-08-01)

Demographic Trends in Paddle Lead Spinal Cord Stimulator Placement: Private Insurance and Medicare Beneficiaries
by: Lawal Labaran, et al.
Published: (2020-06-01)

Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia
by: Yasuhide Kitagawa, et al.
Published: (2015-06-01)

Influence of repeated prostate-specific antigen screening on treatment pattern in a country with a limited social perception of prostate cancer: Korean national wide observational study
by: Young Hwii Ko, et al.
Published: (2021-05-01)

An Empirical Model of Medicare Costs: The Role of Health Insurance, Employment, and Delays in Medicare Enrollment
by: Yuanyuan Deng, et al.
Published: (2021-06-01)

Differences in hospitalizations, emergency room admissions, and outpatient visits among Mexican-American Medicare beneficiaries
by: Brian Downer, et al.
Published: (2019-05-01)

Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001–2014
by: Shawn P. E. Nishi, et al.
Published: (2019-08-01)

Impact of Cost-sharing on Utilization of Medications for Secondary Prevention of Cardiovascular Morbidity and Mortality in Medicare Beneficiaries
by: Olvey, Eleanor
Published: (2011)

The cost of dying on Medicare: an analysis of expenditure data
by: House, Donald Reed
Published: (2005)

Medicare and the U.S. Unfunded Liability
by: Gilbert Berdine
Published: (2013-12-01)

Switching Costs in the Market for Medicare Advantage Plans
by: Nosal, Kathleen Elizabeth
Published: (2012)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Evaluation of the Prevalence, Geographic Spending Variation, and Inpatient Inefficiency Accounting For Spatial Dependence among Medicare Beneficiaries with Epilepsy
by: Ip, Queeny, et al.
Published: (2017)

Impact of Medicare Part D on prescription use, health care expenditures, and health services utilization : national estimates for Medicare beneficiaries and vulnerable populations, 2002 to 2009
by: Cheng, Lung-I
Published: (2012)

Disparities in receipt of recommended care among younger versus older medicare beneficiaries: a cohort study
by: Ling Na, et al.
Published: (2017-03-01)

Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization
by: Wendy Yi Xu, et al.
Published: (2019-06-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)